ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
64 212,72
0,50%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. SeaStar Medical Holding Corporation (ICU)

  7. SeaStar Medical Holding Corporation (ICU) Actualités

ICU SeaStar Medical Holding Corporation

0,4551
-0,0382 (-7,74%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
SeaStar Medical Holding Corporation ICU NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0382 -7,74% 0,4551 06:00:10
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,49 0,4421 0,5093 0,4486 0,4933
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202414:30GLOBESeaStar Medical Announces $3.6 Million NIH Grant Award to..
17/4/202422:00GLOBESeaStar Medical Reports 2023 Financial Results and Provides..
11/4/202414:30GLOBESeaStar Medical to Present at the Noble Capital Markets’..
27/3/202413:30GLOBESeaStar Medical to Restate Financials, Sets Business Update..
12/3/202413:30GLOBESeaStar Medical Provides Updates on Enrollment of Adult..
11/3/202421:05GLOBESeaStar Medical-Sponsored Symposium Featuring Experts..
27/2/202414:30GLOBEManuscript Discussing the Benefit of SeaStar Medical’s..
22/2/202413:58GLOBENuwellis’ Distribution Partner, SeaStar Medical, Receives..
22/2/202413:53GLOBEFDA Grants Humanitarian Device Exemption Approval to SeaStar..
01/2/202414:30GLOBESeaStar Medical Granted Canadian Patent with Broad Claims..
26/1/202414:05GLOBESeaStar Medical Announces Pricing of $9.0 Million Registered..
11/1/202422:05GLOBESeaStar Medical Appoints David A. Green as Chief Financial..
09/1/202414:30GLOBESeaStar Medical Issued U.S. Patent with Broad Claims..
28/12/202314:30GLOBESeaStar Medical Updates Subject Enrollment in its Pivotal..
13/12/202314:30GLOBESeaStar Medical Forms Scientific Advisory Board of..
14/11/202322:04GLOBESeaStar Medical Reports Third Quarter 2023 Financial Results..
31/10/202313:00GLOBENuwellis’ Strategic Partner, SeaStar Medical, Receives FDA..
30/10/202313:00GLOBEFDA Issues Approvable Letter for SeaStar Medical’s Selective..
18/10/202314:30GLOBEFDA Grants SeaStar Medical’s Selective Cytopheretic Device..
05/10/202314:30GLOBESeaStar Medical to Present at the Dawson James Small Cap..
03/10/202322:05GLOBESeaStar Medical Provides Regulatory Update Regarding..
29/9/202314:30GLOBEFDA Grants Breakthrough Device Designation to SeaStar..
21/9/202315:35GLOBEDawson James Securities Announces October Date for 8th..
30/8/202322:35EDGAR2Form 8-K - Current report
29/8/202314:00GLOBECase Series of Three Critically Ill Children with Acute..
24/8/202323:15EDGAR2Form 8-K - Current report
22/8/202314:00GLOBESeaStar Medical to Hold Business Update Conference Call..
17/8/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:45EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202322:43EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202322:41EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202322:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202312:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202312:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202312:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202312:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202312:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/8/202323:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:36EDGAR2Form PRE 14A - Other preliminary proxy statements
14/8/202322:35GLOBESeaStar Medical Reports Second Quarter 2023 Financial..
14/8/202322:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/8/202322:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/8/202322:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/8/202322:00EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
02/8/202322:19EDGAR2Form 8-K - Current report
01/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
20/7/202323:11EDGAR2Form S-1 - General form for registration of securities under..
05/7/202323:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

Dernières Valeurs Consultées

NASDAQ
ICU
SeaStar Medical
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés